Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	1,674	1,591	1,878	1,246	1,546	1,786
Market Cap Growth	3.06%	-15.29%	50.75%	-19.39%	-13.46%	-40.52%
Enterprise Value	663.78	758.36	1,025	525.96	834.39	851.88
Last Close Price	28.14	27.22	32.86	22.27	28.08	32.87
PE Ratio	-	-	2.82	-	-	1.24
PS Ratio	25.34	29.45	51.46	46.45	108.53	-
PB Ratio	1.51	1.33	1.22	1.54	1.40	1.38
P/TBV Ratio	1.48	1.32	1.23	1.53	1.40	1.54
EV/Sales Ratio	10.05	14.04	28.07	19.61	58.59	-
Debt / Equity Ratio	0.02	0.02	0.03	0.07	0.07	0.07
Net Debt / Equity Ratio	-0.63	-0.68	-0.54	-0.87	-0.63	-0.71
Net Debt / EBITDA Ratio	1.49	1.74	1.99	1.83	1.83	2.50
Net Debt / FCF Ratio	1.82	2.16	2.14	2.37	2.22	2.27
Asset Turnover	0.05	0.04	0.03	0.02	0.01	0
Inventory Turnover	0.19	0.21	0.18	0.21	0.40	-
Quick Ratio	12.80	10.52	11.06	11.47	12.54	17.12
Current Ratio	14.19	11.46	11.90	12.27	13.30	17.79
Return on Equity (ROE)	-36.71%	-30.20%	57.29%	-36.83%	-19.38%	189.74%
Return on Assets (ROA)	-38.13%	-31.82%	-30.73%	-35.98%	-29.07%	-33.04%
Return on Invested Capital (ROIC)	-120.28%	-86.82%	-98.25%	-152.37%	-100.31%	-126.02%
Return on Capital Employed (ROCE)	-40.62%	-33.76%	-34.74%	-38.28%	-30.47%	-35.42%
Earnings Yield	-	-	35.42%	-	-	80.77%
Buyback Yield / Dilution	-0.25%	-0.14%	-4.02%	-1.57%	9.36%	12.39%
Total Shareholder Return	-0.25%	-0.14%	-4.02%	-1.57%	9.36%	12.39%

Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q